SCHEMBL8868067

SCHEMBL8868067

CCCOC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCCOCC)cc2)cn1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
P4HTM Q9NXG6 2/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
EGFR P00533 2/20 0.39
MEN1 O00255 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
NAMPT P43490 1/20 0.39
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869141 0.95 P4HTM (0.45) HPGDRAB9ANPC1SMN1; SMN2P4HTM
SCHEMBL8868825 0.95 HPGD (0.46) HPGDRAB9ANPC1SMN1; SMN2P4HTM
SCHEMBL8869147 0.93 P4HTM (0.46) SMN1; SMN2P4HTMPOLBKMT2AALDH1A1
SCHEMBL8868459 0.92 HPGD (0.48) HPGDRAB9ANPC1SMN1; SMN2P4HTM
SCHEMBL8870231 0.91 CA2 (0.47) SMN1; SMN2P4HTMPOLBKMT2AL3MBTL1
SCHEMBL8868717 0.89 P4HTM (0.48) HPGDRAB9ANPC1SMN1; SMN2P4HTM
SCHEMBL8867993 0.89 P4HTM (0.46) HPGDRAB9ANPC1SMN1; SMN2P4HTM
SCHEMBL8869927 0.89 HPGD (0.47) HPGDRAB9ANPC1SMN1; SMN2P4HTM
SCHEMBL8867619 0.89 P4HTM (0.45) HPGDRAB9ANPC1SMN1; SMN2P4HTM
SCHEMBL8867931 0.89 HPGD (0.51) HPGDRAB9ANPC1SMN1; SMN2P4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed